DeepCure is developing a computational drug discovery platform to improve the breadth and accuracy of preclinical drug development, saving up to 80% of preclinical time and cost. DeepCure’s algorithms analyze a trillion drug candidates from its proprietary virtual library, identifying highly effective drugs that are unlikely to be discovered by the conventional drug discovery pipeline.